|
|
PIK90
Description of:PIK90
PIK-90 is a PI3K inhibitor,IC50=11, 350, 18, and 58 for p110 α, β, γ and δ isoforms.
Theor...
更多>>
|
|
|
|
XL765(Voxtalisib)
Description of:XL765
XL765 is a mixed mTOR/PI3k inhibitor with IC50 of 157, 39, 113, 9 and 43 nM for mTOR, p110α, β, γ and &de...
更多>>
|
|
|
|
CAL101(Acalisib)
Description of:CAL101
CAL-101 blocked constitutive phosphatidylinositol-3-kinase signaling, resulting in decreased phosphorylation of Akt and o...
更多>>
|
|
|
|
A66
Description of:A66
A66 is a highly specific and selective p110α inhibitor with IC50 of 32,30 and 43 nM for p110α, p110α...
更多>>
|
|
|
|
PIK-75
Description of:PIK-75
Cell-based assays revealed that PIK-75 potently and dose dependently inhibits in vitro and in vivo production of TNF-alph...
更多>>
|
|
|
|
Pictilisib(GDC-0941)
Description of:GDC-0941
GDC-0941 was much less potent on mTOR and DNA-PK. Importantly, the activity of GDC-0941 against the panel of human tumo...
更多>>
|
|
|
|
BEZ235(NVP-BEZ235)
Description of:BEZ235(NVP-BEZ235)
NVP-BEZ235 inhibited the activation of the downstream effectors Akt, S6 ribosomal protein, and 4EBP1 in breas...
更多>>
|
|
|
|
ZSTK474
Description of:ZSTK474
ZSTK474 has strong antitumor activities against human cancer xenografts (A549, PC-3 and WiDr) when administered orally t...
更多>>
|
|
|
|
NVP-BKM120(Buparlisib)
Description of:NVP-BKM120
NVP-BKM120 is a potent, selective, orally bioavailable Class I PI3 Kinase Inhibitor for treating Cancer.
The...
更多>>
|
|
Chromatin/Epigenetics
AMPK
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian